Evidence map›Paper›PMID 32434548›Full record

ArticleBMC pharmacology & toxicology2020

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report.

Victoria Rodriguez, Kieran Hanley, Ana Julia Arias, Diego Quattrone, Joseph Kuforiji, Eromona Whiskey, Sukhi S Shergill

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC pharmacology & toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Victoria RodriguezDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Denmark hill, London, SE5 9RS, UK. victoria.1.rodriguez@kcl.ac.uk.ORCID 0000-0003-0383-0846
Kieran HanleySouth London and Maudsley NHS Foundation Trust, London, UK.
Ana Julia AriasHospital de Salud Mental "El Sauce", Mendoza, Argentina.
Diego QuattroneClinical Research Fellow, Social Genetic & Developmental Psychiatry, King's College London, and National Psychosis Unit, Bethlem Royal Hospital, London, UK.
Joseph KuforijiNational Psychosis Unit, Bethlem Royal Hospital, London, UK.
Eromona WhiskeyNational Psychosis Service, and Pharmacy Department, South London and Maudsley NHS Foundation Trust, London, UK.
Sukhi S ShergillNational Psychosis Unit, Bethlem Royal Hospital, London, UK.
Bethlem Royal Hospital · GBKing's College London · GBSouth London and Maudsley NHS Foundation Trust · GBUniversity of Mendoza · AR

Funding

National Institute for Health Research ERC Consolidator Award
6 · The paper itself

Abstract

backgroundAcute pancreatitis is a rare but recognised complication of clozapine leading to termination of treatment. CASE PRESENTATION: We present the case of a 39-year-old man with treatment-resistant schizoaffective disorder and a history of recurrent acute pancreatitis attributed to clozapine. After 15 years of unremitting symptoms with disruptive and aggressive behaviour, he was admitted for a clozapine rechallenge. Despite experiencing two further episodes of acute pancreatitis during clozapine treatment that led to its temporary withdrawal, clozapine was successfully re-established under gastroenterology consultation with close monitoring which resulted in progressively marked improvement of his mental state.

conclusionsThis case demonstrates that patients who develop pancreatitis during clozapine treatment may be cautiously rechallenged with specialist gastroenterology support.

Indexed as

Acute DiseaseAdultAntipsychotic AgentsClozapineHumansMalePancreatitisPsychotic DisordersAntipsychotic AgentsClozapineAcute pancreatitisClozapineRe-challengeSchizophreniaSide effects

Identifiers

PMID32434548
PMCPMC7238513
OpenAlexW3027949539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.